FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378530090> ?p ?o ?g. }

• W4378530090 endingPage "104049" @default.
• W4378530090 startingPage "104049" @default.
• W4378530090 abstract "Opioid drug-related deaths continue to be a significant public health concern in the Republic of Ireland (ROI) and Northern Ireland (NI). While both regions have implemented naloxone to reduce drug related deaths, there remains a gap in the implementation of a supervised injection facility (SIF). This study aimed to identify barriers and facilitators to implementing naloxone and a SIF to reduce opioid drug-related deaths in ROI and NI. Semi-structured interviews (n=23) were conducted in ROI and NI with experts by experience (n=8), staff from low threshold services (n=9), and individuals involved in policy making (n= 6). Data were analyzed using coding reliability Thematic Analysis and were informed by the Risk Environmental Framework. The findings illustrated that stigma within the media, health centers, and the community was a significant barrier to naloxone distribution and SIF implementation. Policing and community intimidation were reported to hinder naloxone carriage in both the ROI and NI, while threats of paramilitary violence towards people who use drugs were unique to NI. Municipal government delays and policy maker apathy were reported to hinder SIF implementation in the ROI. Participants suggested peer-to-peer naloxone delivery and amending legislation to facilitate non-prescription naloxone would increase naloxone uptake. Participants recommended using webinars, Town Halls, and a Citizens’ Assembly as tools to advocate for SIF implementation. Local and regional stigma reduction campaigns are needed in conjunction with policy changes to advance naloxone and a SIF. Tailoring stigma campaigns to incorporate the lived experience of people who use drugs, their family members, and the general community can aid in educating the public and change negative perceptions. This study highlights the need for ongoing efforts to reduce stigma and increase accessibility to evidence-based interventions to address opioid drug-related deaths in the ROI, NI, and internationally." @default.
• W4378530090 created "2023-05-28" @default.
• W4378530090 creator A5019622393 @default.
• W4378530090 creator A5078818919 @default.
• W4378530090 creator A5017577527 @default.
• W4378530090 date "2023-07-01" @default.
• W4378530090 modified "2023-09-30" @default.
• W4378530090 title "Barriers and facilitators of naloxone and safe injection facility interventions to reduce opioid drug-related deaths: A qualitative analysis" @default.
• W4378530090 cites W1934945143 @default.
• W4378530090 cites W2010898122 @default.
• W4378530090 cites W2017933780 @default.
• W4378530090 cites W2036022242 @default.
• W4378530090 cites W2050397435 @default.
• W4378530090 cites W2055630850 @default.
• W4378530090 cites W2081229204 @default.
• W4378530090 cites W2103936157 @default.
• W4378530090 cites W2109202572 @default.
• W4378530090 cites W2110101976 @default.
• W4378530090 cites W2113129500 @default.
• W4378530090 cites W2133674686 @default.
• W4378530090 cites W2138664283 @default.
• W4378530090 cites W2141693119 @default.
• W4378530090 cites W2143606268 @default.
• W4378530090 cites W2163915813 @default.
• W4378530090 cites W2165639864 @default.
• W4378530090 cites W2263744508 @default.
• W4378530090 cites W2559845726 @default.
• W4378530090 cites W2752001084 @default.
• W4378530090 cites W2765615977 @default.
• W4378530090 cites W2782273569 @default.
• W4378530090 cites W2792522767 @default.
• W4378530090 cites W2885059679 @default.
• W4378530090 cites W2885226220 @default.
• W4378530090 cites W2894353649 @default.
• W4378530090 cites W2955921782 @default.
• W4378530090 cites W2982578727 @default.
• W4378530090 cites W2984257468 @default.
• W4378530090 cites W2990927624 @default.
• W4378530090 cites W2996597775 @default.
• W4378530090 cites W2998815538 @default.
• W4378530090 cites W3001894749 @default.
• W4378530090 cites W3011296856 @default.
• W4378530090 cites W3034962419 @default.
• W4378530090 cites W3039366822 @default.
• W4378530090 cites W3042589715 @default.
• W4378530090 cites W3084091505 @default.
• W4378530090 cites W3086530579 @default.
• W4378530090 cites W3092779821 @default.
• W4378530090 cites W3105277598 @default.
• W4378530090 cites W3126407038 @default.
• W4378530090 cites W3154463802 @default.
• W4378530090 cites W3156214019 @default.
• W4378530090 cites W3162761412 @default.
• W4378530090 cites W3177916459 @default.
• W4378530090 cites W3196754849 @default.
• W4378530090 cites W4200580763 @default.
• W4378530090 cites W4214545163 @default.
• W4378530090 cites W4220783570 @default.
• W4378530090 cites W4220953768 @default.
• W4378530090 cites W4221018934 @default.
• W4378530090 cites W4225398733 @default.
• W4378530090 cites W4225854097 @default.
• W4378530090 cites W4297457600 @default.
• W4378530090 doi "https://doi.org/10.1016/j.drugpo.2023.104049" @default.
• W4378530090 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37247475" @default.
• W4378530090 hasPublicationYear "2023" @default.
• W4378530090 type Work @default.
• W4378530090 citedByCount "0" @default.
• W4378530090 crossrefType "journal-article" @default.
• W4378530090 hasAuthorship W4378530090A5017577527 @default.
• W4378530090 hasAuthorship W4378530090A5019622393 @default.
• W4378530090 hasAuthorship W4378530090A5078818919 @default.
• W4378530090 hasBestOaLocation W43785300901 @default.
• W4378530090 hasConcept C118552586 @default.
• W4378530090 hasConcept C126322002 @default.
• W4378530090 hasConcept C138816342 @default.
• W4378530090 hasConcept C144024400 @default.
• W4378530090 hasConcept C159110408 @default.
• W4378530090 hasConcept C170493617 @default.
• W4378530090 hasConcept C190248442 @default.
• W4378530090 hasConcept C27415008 @default.
• W4378530090 hasConcept C2778750930 @default.
• W4378530090 hasConcept C2781063702 @default.
• W4378530090 hasConcept C36289849 @default.
• W4378530090 hasConcept C529928208 @default.
• W4378530090 hasConcept C71924100 @default.
• W4378530090 hasConcept C74196892 @default.
• W4378530090 hasConceptScore W4378530090C118552586 @default.
• W4378530090 hasConceptScore W4378530090C126322002 @default.
• W4378530090 hasConceptScore W4378530090C138816342 @default.
• W4378530090 hasConceptScore W4378530090C144024400 @default.
• W4378530090 hasConceptScore W4378530090C159110408 @default.
• W4378530090 hasConceptScore W4378530090C170493617 @default.
• W4378530090 hasConceptScore W4378530090C190248442 @default.
• W4378530090 hasConceptScore W4378530090C27415008 @default.
• W4378530090 hasConceptScore W4378530090C2778750930 @default.
• W4378530090 hasConceptScore W4378530090C2781063702 @default.
• W4378530090 hasConceptScore W4378530090C36289849 @default.

• next